{
  "DOI": "10.1007/s10689-010-9377-y",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-010-9377-y",
  "alternative-id": [
    "9377"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Ginsburg",
      "given": "Ophira M.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "name": "Hereditary Breast Cancer Clinical Study Group",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Kim-Sing",
      "given": "Charmaine",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Foulkes",
      "given": "William D.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ghadirian",
      "given": "Parviz",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lynch",
      "given": "Henry T.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sun",
      "given": "Ping",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Narod",
      "given": "Steven A.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2010,
        8,
        31
      ]
    ],
    "date-time": "2010-08-31T09:14:23Z",
    "timestamp": 1283246063000
  },
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        30
      ]
    ],
    "date-time": "2019-05-30T21:46:04Z",
    "timestamp": 1559252764000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        5
      ]
    ],
    "date-time": "2024-04-05T00:17:35Z",
    "timestamp": 1712276255430
  },
  "is-referenced-by-count": 26,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "4",
  "issued": {
    "date-parts": [
      [
        2010,
        9,
        1
      ]
    ]
  },
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2010,
          12
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2010,
            9,
            1
          ]
        ],
        "date-time": "2010-09-01T00:00:00Z",
        "timestamp": 1283299200000
      }
    }
  ],
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-010-9377-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/s10689-010-9377-y/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/s10689-010-9377-y",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "489-493",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2010,
        9,
        1
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2010,
        9,
        1
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2010,
        12
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/S0140-6736(94)91578-4",
      "author": "D Ford",
      "doi-asserted-by": "crossref",
      "first-page": "692",
      "journal-title": "Lancet",
      "key": "9377_CR1",
      "unstructured": "Ford D, Easton D, Bishop T, Narod S et al (1994) Risk of cancer in BRCA1 mutation carriers. Lancet 343:692–695",
      "volume": "343",
      "year": "1994"
    },
    {
      "DOI": "10.1093/jnci/91.15.1310",
      "author": "The Breast Cancer Linkage Consortium",
      "doi-asserted-by": "crossref",
      "first-page": "1310",
      "journal-title": "J Natl Cancer Inst",
      "key": "9377_CR2",
      "unstructured": "The Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91:1310–1316",
      "volume": "91",
      "year": "1999"
    },
    {
      "DOI": "10.1093/jnci/94.18.1358",
      "author": "D Thompson",
      "doi-asserted-by": "crossref",
      "first-page": "1358",
      "journal-title": "J Natl Cancer Inst",
      "key": "9377_CR3",
      "unstructured": "Thompson D, Easton DF (2002) Breast cancer linkage consortium. Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst 94:1358–1365",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1093/jnci/94.18.1365",
      "author": "M Brose",
      "doi-asserted-by": "crossref",
      "first-page": "1365",
      "journal-title": "J Natl Cancer Inst",
      "key": "9377_CR4",
      "unstructured": "Brose M, Rebbeck T, Calzone K et al (2002) Cancer risk estimates for BRCA1 mutation carriers identified in a cancer risk evaluation program. J Natl Cancer Inst 94:1365–1372",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1016/S0959-8049(99)00135-5",
      "author": "O Johannsson",
      "doi-asserted-by": "crossref",
      "first-page": "1248",
      "journal-title": "Eur J Cancer",
      "key": "9377_CR5",
      "unstructured": "Johannsson O, Loman N, Moller T, Kristoffersson U, Borg A, Olsson H (1999) Incidence of malignant tumors in relatives of BRCA1 and BRCA2 germ-line mutation carriers. Eur J Cancer 35:1248–1257",
      "volume": "35",
      "year": "1999"
    },
    {
      "DOI": "10.1093/annonc/mdh474",
      "author": "JL Bermejo",
      "doi-asserted-by": "crossref",
      "first-page": "1834",
      "journal-title": "Ann Oncol",
      "key": "9377_CR6",
      "unstructured": "Bermejo JL, Hemminki K (2004) Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing. Ann Oncol 15:1834–1841",
      "volume": "15",
      "year": "2004"
    },
    {
      "author": "H Shih",
      "first-page": "4259",
      "journal-title": "Clin Cancer Res",
      "key": "9377_CR7",
      "unstructured": "Shih H, Nathanson K, Seal S, Collins N, Stratton M, Rebbeck T, Weber B (2000) BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers. Clin Cancer Res 6:4259–4264",
      "volume": "6",
      "year": "2000"
    },
    {
      "DOI": "10.1086/513891",
      "author": "D Easton",
      "doi-asserted-by": "crossref",
      "first-page": "120",
      "journal-title": "Am J Hum Genet",
      "key": "9377_CR8",
      "unstructured": "Easton D, Steele L, Fields P, Ormiston W et al (1997) Cancer risks in two large breast cancer families linked to BRCA2 on Chromosome 13q12–13. Am J Hum Genet 61:120–128",
      "volume": "61",
      "year": "1997"
    },
    {
      "DOI": "10.1086/302853",
      "author": "R Moslehi",
      "doi-asserted-by": "crossref",
      "first-page": "1259",
      "journal-title": "Am J Hum Genet",
      "key": "9377_CR9",
      "unstructured": "Moslehi R, Chu W, Karlan B et al (2000) BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am J Hum Genet 66:1259–1272",
      "volume": "66",
      "year": "2000"
    },
    {
      "DOI": "10.1086/318787",
      "author": "H Risch",
      "doi-asserted-by": "crossref",
      "first-page": "700",
      "journal-title": "Am J Hum Genet",
      "key": "9377_CR10",
      "unstructured": "Risch H, McLaughlin J, Cole D, Rosen B et al (2001) Prevalence of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 68:700–710",
      "volume": "68",
      "year": "2001"
    },
    {
      "DOI": "10.1023/A:1025428807472",
      "author": "P Aretini",
      "doi-asserted-by": "crossref",
      "first-page": "71",
      "journal-title": "Breast Cancer Res Treat",
      "key": "9377_CR11",
      "unstructured": "Aretini P, D’ Andrea E, Pasini B, Viel A et al (2003) Different expressivity of BRCA1 and BRCA2: analysis of 179 Italian pedigrees with identified mutation. Breast Cancer Res Treat 81:71–79",
      "volume": "81",
      "year": "2003"
    },
    {
      "DOI": "10.1056/NEJM199705153362001",
      "author": "J Streuwing",
      "doi-asserted-by": "crossref",
      "first-page": "1401",
      "journal-title": "N Engl J Med",
      "key": "9377_CR12",
      "unstructured": "Streuwing J, Hartge P, Wacholder S et al (1997) The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401–1408",
      "volume": "336",
      "year": "1997"
    },
    {
      "DOI": "10.1093/jnci/86.21.1600",
      "author": "DE Goldgar",
      "doi-asserted-by": "crossref",
      "first-page": "1600",
      "journal-title": "J Natl Cancer Inst",
      "key": "9377_CR13",
      "unstructured": "Goldgar DE, Easton DF, Cannon-Albright L, Skolnick M (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600–1608",
      "volume": "86",
      "year": "1994"
    },
    {
      "author": "D Berman",
      "first-page": "3409",
      "journal-title": "Cancer Res",
      "key": "9377_CR14",
      "unstructured": "Berman D, Costalas J, Schultz D, Grana G, Daly M, Godwin A (1996) A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish and non-Jewish individuals. Cancer Res 56:3409–3414",
      "volume": "56",
      "year": "1996"
    },
    {
      "DOI": "10.1093/jnci/95.3.214",
      "author": "S Hahn",
      "doi-asserted-by": "crossref",
      "first-page": "214",
      "journal-title": "J Natl Cancer Inst",
      "key": "9377_CR15",
      "unstructured": "Hahn S, Greenhalf B, Ellis I, Sina-Frey M et al (2003) BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst 95:214–221",
      "volume": "95",
      "year": "2003"
    },
    {
      "author": "K Murphy",
      "first-page": "3789",
      "journal-title": "Cancer Res",
      "key": "9377_CR16",
      "unstructured": "Murphy K, Brune K, Griffin C, Sollenberger J et al (2002) Evaluation of candidate genes MPP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res 62:3789–3793",
      "volume": "62",
      "year": "2002"
    },
    {
      "author": "G Lal",
      "first-page": "409",
      "journal-title": "Cancer Res",
      "key": "9377_CR17",
      "unstructured": "Lal G, Liu G, Schmocker B et al (2000) Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1 and BRCA2 mutations. Cancer Res 60:409–416",
      "volume": "60",
      "year": "2000"
    },
    {
      "DOI": "10.1158/1078-0432.CCR-03-0604",
      "author": "T Kirchhoff",
      "doi-asserted-by": "crossref",
      "first-page": "2918",
      "journal-title": "Clin Cancer Res",
      "key": "9377_CR18",
      "unstructured": "Kirchhoff T, Kauff N, Mitra N et al (2004) BRCA mutations and the risk of prostate cancer in Ashkenazi Jews. Clin Cancer Res 10:2918–2921",
      "volume": "10",
      "year": "2004"
    },
    {
      "DOI": "10.1086/345310",
      "author": "SM Edwards",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "journal-title": "Am J Hum Genet",
      "key": "9377_CR19",
      "unstructured": "Edwards SM, Kote-Jarai Z, Meitz J et al (2003) Two percent of men with early onset prostate cancer harbor germline mutations in the BRCA2 gene. Am J Hum Genet 72:1–12",
      "volume": "72",
      "year": "2003"
    },
    {
      "DOI": "10.1054/bjoc.2000.1249",
      "author": "A Vazina",
      "doi-asserted-by": "crossref",
      "first-page": "463",
      "journal-title": "Br J Cancer",
      "key": "9377_CR20",
      "unstructured": "Vazina A, Baniel J, Shtriker A et al (2000) The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel. Br J Cancer 83:463–466",
      "volume": "83",
      "year": "2000"
    },
    {
      "DOI": "10.1086/302525",
      "author": "A Hubert",
      "doi-asserted-by": "crossref",
      "first-page": "921",
      "journal-title": "Am J Hum Genet",
      "key": "9377_CR21",
      "unstructured": "Hubert A, Peretz T, Manor O et al (1999) The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer. Am J Hum Genet 65:921–924",
      "volume": "65",
      "year": "1999"
    },
    {
      "DOI": "10.1016/S0140-6736(98)03300-5",
      "author": "S Thorlacius",
      "doi-asserted-by": "crossref",
      "first-page": "1337",
      "journal-title": "Lancet",
      "key": "9377_CR22",
      "unstructured": "Thorlacius S, Struewing J, Hartge P et al (1998) Population based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 352:1337–1339",
      "volume": "352",
      "year": "1998"
    },
    {
      "DOI": "10.1007/s001090050162",
      "author": "S Sigurdsson",
      "doi-asserted-by": "crossref",
      "first-page": "758",
      "journal-title": "J Mol Med",
      "key": "9377_CR23",
      "unstructured": "Sigurdsson S, Thorlaciaus S, Tomasson J et al (1997) BRCA2 mutation in Icelandic prostate cancer patients. J Mol Med 75:758–761",
      "volume": "75",
      "year": "1997"
    },
    {
      "DOI": "10.1002/ijc.10155",
      "author": "J Iscovich",
      "doi-asserted-by": "crossref",
      "first-page": "42",
      "journal-title": "Int J Cancer",
      "key": "9377_CR24",
      "unstructured": "Iscovich J, Abdulrazik M, Cour C et al (2002) Prevalence of the BRCA2 6174 del T mutation in Israeli uveal melanoma patients. Int J Cancer 98:42–44",
      "volume": "98",
      "year": "2002"
    },
    {
      "DOI": "10.1002/ijc.10693",
      "author": "R Scott",
      "doi-asserted-by": "crossref",
      "first-page": "188",
      "journal-title": "Int J Cancer",
      "key": "9377_CR25",
      "unstructured": "Scott R, Vajdic C, Armstrong B et al (2002) BRCA2 mutations in a population based series of patients with ocular melanoma. Int J Cancer 102:188–191",
      "volume": "102",
      "year": "2002"
    },
    {
      "DOI": "10.1093/jnci/djh008",
      "author": "B Niell",
      "doi-asserted-by": "crossref",
      "first-page": "15",
      "journal-title": "J Natl Cancer Inst",
      "key": "9377_CR26",
      "unstructured": "Niell B, Rennert G, Bonner J, Almog R, Tomsho L, Gruber S (2004) BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer. J Natl Cancer Inst 96:15–21",
      "volume": "96",
      "year": "2004"
    },
    {
      "DOI": "10.1093/jnci/djh006",
      "author": "T Kirchhoff",
      "doi-asserted-by": "crossref",
      "first-page": "68",
      "journal-title": "J Natl Cancer Inst",
      "key": "9377_CR27",
      "unstructured": "Kirchhoff T, Satagopan J, Kauff N et al (2004) Frequency of BRCA1 and BRCA2 mutations in unselected Ashkenazi Jewish patients with colorectal cancer. J Natl Cancer Inst 96:68–70",
      "volume": "96",
      "year": "2004"
    },
    {
      "DOI": "10.1054/bjoc.2000.1598",
      "author": "R Chen-Stoyerman",
      "doi-asserted-by": "crossref",
      "first-page": "475",
      "journal-title": "Br J Cancer",
      "key": "9377_CR28",
      "unstructured": "Chen-Stoyerman R, Figer A, Fidder H et al (2001) The frequency of the predominant Jewish mutations in BRCA1 and BRCA2 in unselected Ashkenazi colorectal cancer patients. Br J Cancer 84:475–477",
      "volume": "84",
      "year": "2001"
    },
    {
      "author": "L Drucker",
      "first-page": "559",
      "journal-title": "Anticancer Res",
      "key": "9377_CR29",
      "unstructured": "Drucker L, Stackievitz R, Shpitz B, Yarkoni S (2000) Incidence of BRCA1 and BRCA2 mutations in Ashkenazi colorectal cancer patients: preliminary study. Anticancer Res 20:559–561",
      "volume": "20",
      "year": "2000"
    },
    {
      "DOI": "10.1093/jnci/94.16.1221",
      "author": "CB Begg",
      "doi-asserted-by": "crossref",
      "first-page": "1221",
      "journal-title": "J Natl Cancer Inst",
      "key": "9377_CR30",
      "unstructured": "Begg CB (2002) On the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 94:1221–1226",
      "volume": "94",
      "year": "2002"
    },
    {
      "DOI": "10.1093/jnci/95.1.74",
      "author": "CR Amos",
      "doi-asserted-by": "crossref",
      "first-page": "74",
      "journal-title": "J Natl Cancer Inst",
      "key": "9377_CR31",
      "unstructured": "Amos CR (2003) Re: on the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 95:74–75",
      "volume": "95",
      "year": "2003"
    },
    {
      "DOI": "10.1093/jnci/95.1.73-a",
      "author": "H Risch",
      "doi-asserted-by": "crossref",
      "first-page": "73",
      "journal-title": "J Natl Cancer Inst",
      "key": "9377_CR32",
      "unstructured": "Risch H, Narod S (2003) Re: on the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 95:73–74",
      "volume": "95",
      "year": "2003"
    },
    {
      "DOI": "10.1093/jnci/95.1.75",
      "author": "PP Pharoah",
      "doi-asserted-by": "crossref",
      "first-page": "75",
      "journal-title": "J Natl Cancer Inst",
      "key": "9377_CR33",
      "unstructured": "Pharoah PP, Antoniou A, Hopper J, Easton D (2003) Re: on the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 95:75–76",
      "volume": "95",
      "year": "2003"
    },
    {
      "DOI": "10.1093/jnci/95.1.76",
      "author": "AS Whittemore",
      "doi-asserted-by": "crossref",
      "first-page": "76",
      "journal-title": "J Natl Cancer Inst",
      "key": "9377_CR34",
      "unstructured": "Whittemore AS, Gong G (2003) Re: on the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 95:76–77",
      "volume": "95",
      "year": "2003"
    },
    {
      "DOI": "10.1093/jnci/95.1.78",
      "author": "W Burke",
      "doi-asserted-by": "crossref",
      "first-page": "78",
      "journal-title": "J Natl Cancer Inst",
      "key": "9377_CR35",
      "unstructured": "Burke W, Austin MA (2003) Re: on the use of familial aggregation in population-based case probands for calculating penetrance. J Natl Cancer Inst 95:78–79",
      "volume": "95",
      "year": "2003"
    },
    {
      "DOI": "10.1126/science.306.5705.2187c",
      "author": "DF Easton",
      "doi-asserted-by": "crossref",
      "first-page": "2187",
      "journal-title": "Science",
      "key": "9377_CR36",
      "unstructured": "Easton DF, Hopper JL, Thomas DL, Antoniou A, Pharoah PDP, Whittemore AS (2004) Re: breast cancer risks for BRCA1/2 carriers. Science 306:2187–2188",
      "volume": "306",
      "year": "2004"
    },
    {
      "author": "S Wacholder",
      "first-page": "2188",
      "journal-title": "Science",
      "key": "9377_CR37",
      "unstructured": "Wacholder S, Struewing JP, Hartage P, Greene MH, Tucker MA (2004) Re: breast cancer risks for BRCA1/2 carriers. Science 306:2188",
      "volume": "306",
      "year": "2004"
    },
    {
      "author": "MC King",
      "first-page": "2188",
      "journal-title": "Science",
      "key": "9377_CR38",
      "unstructured": "King MC, New York Breast Cancer Study Group (2004) Re: breast cancer risks for BRCA1/2 carriers. Science 306:2188–2191",
      "volume": "306",
      "year": "2004"
    },
    {
      "DOI": "10.1093/jnci/djj500",
      "author": "K Offit",
      "doi-asserted-by": "crossref",
      "first-page": "1675",
      "issue": "23",
      "journal-title": "J Natl Cancer Inst",
      "key": "9377_CR39",
      "unstructured": "Offit K (2006) BRCA mutation frequency and penetrance: new data, old debate. J Natl Cancer Inst 98(23):1675–1677",
      "volume": "98",
      "year": "2006"
    },
    {
      "author": "DR Easton",
      "first-page": "256",
      "journal-title": "Am J Hum Genet",
      "key": "9377_CR40",
      "unstructured": "Easton DR, Ford D, Bishop DT (1995) Breast and ovarian incidence in BRCA1-mutartion carriers. Am J Hum Genet 56:256–271",
      "volume": "56",
      "year": "1995"
    },
    {
      "DOI": "10.1186/bcr632",
      "author": "N Loman",
      "doi-asserted-by": "crossref",
      "first-page": "R175",
      "journal-title": "Breast Cancer Res",
      "key": "9377_CR41",
      "unstructured": "Loman N, Bladstrom A, Johannsson O, Borg A, Olsson H (2003) Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status. Breast Cancer Res 5:R175–R186",
      "volume": "5",
      "year": "2003"
    },
    {
      "DOI": "10.1016/S0190-9622(08)81509-5",
      "author": "DL Miller",
      "doi-asserted-by": "crossref",
      "first-page": "774",
      "journal-title": "J Am Acad Derm",
      "key": "9377_CR42",
      "unstructured": "Miller DL, Weinstock MA (1994) Nonmelanoma skin cancer in the United States: incidence. J Am Acad Derm 30:774–778",
      "volume": "30",
      "year": "1994"
    },
    {
      "key": "9377_CR43",
      "unstructured": "SEER 17 (2000–2006). http://seer.cancer.gov"
    },
    {
      "DOI": "10.1038/sj.bjc.6603535",
      "author": "E Levy-Lahad",
      "doi-asserted-by": "crossref",
      "first-page": "11",
      "journal-title": "British J Cancer",
      "key": "9377_CR44",
      "unstructured": "Levy-Lahad E, Friedman E (2007) Cancer risks among BRCA1 and BRCA2 carriers: minireview. British J Cancer 96:11–15",
      "volume": "96",
      "year": "2007"
    },
    {
      "DOI": "10.1002/ijc.10155",
      "author": "J Iscovitch",
      "doi-asserted-by": "crossref",
      "first-page": "42",
      "journal-title": "Int J Cancer",
      "key": "9377_CR45",
      "unstructured": "Iscovitch J, Abdulrazik M, Cour C et al (2002) Prevalence of the BRCA2 6174delT mutation in uveal melanoma patients. Int J Cancer 98:42–44",
      "volume": "98",
      "year": "2002"
    },
    {
      "DOI": "10.1007/s10689-008-9206-8",
      "author": "L Kadouri",
      "doi-asserted-by": "crossref",
      "first-page": "29",
      "journal-title": "Fam Cancer",
      "key": "9377_CR46",
      "unstructured": "Kadouri L, Temper M, Grenader T, Abeliovich D, Hamburger T, Peretz T, Lotem M (2009) Absence of founder BRCA1 and BRCA2 mutations in cutaneous malignant melanoma patients of Ashkenazi origin. Fam Cancer 8:29–32",
      "volume": "8",
      "year": "2009"
    },
    {
      "DOI": "10.1007/s10689-007-9143-y",
      "author": "C Monerrat",
      "doi-asserted-by": "crossref",
      "first-page": "453",
      "journal-title": "Fam Cancer",
      "key": "9377_CR47",
      "unstructured": "Monerrat C, Chompret A, Kannengiesser C, Avril M-F et al (2007) BRCA1, BRCA2, CDKN2a germline mutations in patients with breast cancer and cutaneous melanoma. Fam Cancer 6:453–461",
      "volume": "6",
      "year": "2007"
    },
    {
      "DOI": "10.4161/cbt.4.12.2378",
      "author": "A Navaraj",
      "doi-asserted-by": "crossref",
      "first-page": "1409",
      "journal-title": "Cancer Biol Ther",
      "key": "9377_CR48",
      "unstructured": "Navaraj A, Mori T, El-Deiry WS (2005) Cooperation between BRCA1 and p53 in repair of cyclobutane pyrimidine dimers. Cancer Biol Ther 4:1409–1414",
      "volume": "4",
      "year": "2005"
    }
  ],
  "reference-count": 48,
  "references-count": 48,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/s10689-010-9377-y"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "BRCA1 and BRCA2 families and the risk of skin cancer"
  ],
  "type": "journal-article",
  "volume": "9"
}